Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Doximity, Inc. Class A Common Stock (NY:DOCS)

51.42 -0.15 (-0.29%)
Streaming Delayed Price Updated: 10:31 AM EDT, Apr 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Doximity, Inc. Class A Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
7 Best New Stocks on Robinhood Making Waves on the Platform
Robinhood stocks took off during the pandemic as millennials spent stimulus funds on the market, and these picks can continue to thrive. 
Via InvestorPlace
Why Jim Cramer Likes Illumina And Enterprise Products Partners
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: 
Via Benzinga
A New Year Won’t Fix Teladoc’s Long-Term Prognosis
Teladoc is losing tons of money and TDOC stock isn't cheap on other metrics. As such, shares are a clear "avoid" for the time being. 
Via InvestorPlace
EXCLUSIVE: Looking Back On The Best And Worst IPOs Of 2021 With IPO Warriors
2021 was a record year for IPOs. More than 1,000 companies made public debuts, raising about $315 billion in the process. The previous record of about $200 billion... 
Via Benzinga
Where Doximity Stands With Analysts
Within the last quarter, Doximity (NYSE:DOCS) has observed the following anal... 
Via Benzinga
Expert Ratings For Doximity
Analysts have provided the following ratings for Doximity (NYSE:DOCS) within... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price... 
Via Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
Gainers Calliditas Therapeutics AB (NASDAQ: CALT) shares climbed 28.7% to $24.13 after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce... 
Via Benzinga
Jim Cramer Prefers NortonLifeLock Over McAfee
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers NortonLifeLock Inc. (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021
Upgrades According to Wells Fargo, the prior rating for Douglas Emmett Inc (NYSE: 
Via Benzinga
Cramer Gives His Opinion On GlaxoSmithKline, Asana And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Penn National Gaming, Inc. (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2021
Upgrades According to William Blair, the prior rating for Graco Inc (NYSE: 
Via Benzinga
Jim Cramer Likes This Stock Over Cassava Sciences And Biogen
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cassava Sciences, Inc. (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE: 
Via Benzinga
Stock Market Rally Cools On Hot Inflation; Rivian IPO Revs Higher, Elon Musk Sells Tesla Shares; GE, J&J Plan Breakups: Weekly Review
The market rally paused its big run as inflation spiked. The Rivian IPO soared in its debut while Musk sold some Tesla shares. 
Via Investor's Business Daily
Topics Initial Public Offering Stocks
Exposures Securities Market US Equities
Doximity Stock Flashes Robust Vital Signs
Doximity sees its Relative Strength Rating hit the elite 90-plus level. 
Via Investor's Business Daily
Here's Why Doximity Stock Is Down Today
Third-quarter earnings were positive, but the stock market is focused on the impending end of lock-up agreements. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! It's time to start another busy day of trading with a dive into the biggest pre-market stock movers for Wednesday. 
Via InvestorPlace
This Healthcare Stock Has a Huge Reach and Massive Revenue Growth Potential
Amazing market penetration and untapped revenue potential make a nice combination. 
Via The Motley Fool
These 2 Telehealth Companies Should Unite
Here's why Doximity and OptimizeRx might want to consider a merger. 
Via The Motley Fool
3 Leading Telehealth Stocks to Buy in 2021 and Beyond
All three of these telehealth companies are already profitable and have solid financials. 
Via The Motley Fool
Cramer Recommends To Hold Doximity, Avoid This Industry And Buy This Stock
On CNBC’s “Mad Money... 
Via Benzinga
1 Top Telehealth Stock to Buy for the Long Haul
GoodRx is transforming the way people pay for prescriptions, and it is using telehealth to do it. 
Via The Motley Fool
3 COVID Stocks That Can Turn $1,000 Into $10,000
Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic. 
Via The Motley Fool
Exposures COVID-19
This Is Healthcare Platform Doximity's Biggest Advantage
It's hard to beat a strong network effect. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
The Best Social Media Stock You've Probably Never Heard Of
This network for doctors hosted more virtual visits than Teladoc last year. 
Via The Motley Fool
Up 68% from Its IPO, Is Doximity Still Worth Buying?
Doximity has seen tremendous share price growth since its IPO, and if it succeeds in expanding its market opportunity, this could continue. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Cramer Gives His Opinion On Carnival Corp, Doximity And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Carnival Corp (NYSE: CCL) is good, but Norwegian Cruise Line Holdings Ltd (NYSE: NCLH) is better. Duolingo Inc... 
Via Benzinga
2 Top Telehealth Stocks to Buy for the Long Haul
The healthcare industry is changing. Investors should adapt. 
Via The Motley Fool
Exposures COVID-19
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.